成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 872573-93-8 Chemical Structure| 872573-93-8
Chemical Structure| 872573-93-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 872573-93-8

,{[proInfo.pro_purity]}

Ro 3306 is a potent and selective inhibitor of CDK1 with Ki value of 35 nM for CDK1/cyclin B1, 10-fold selectivity relative to CDK2/cyclin E and > 50-fold relative to CDK4/cyclin D.

Synonyms: Ro-3306

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of RO-3306

CAS No. :872573-93-8
Formula : C18H13N3OS2
M.W : 351.45
SMILES Code : O=C1N=C(NCC2=CC=CS2)S/C1=C/C3=CC=C4N=CC=CC4=C3
Synonyms :
Ro-3306
MDL No. :MFCD17392573
InChI Key :XOLMRFUGOINFDQ-YBEGLDIGSA-N
Pubchem ID :135400873

Safety of RO-3306

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of RO-3306

Hedgehog

Isoform Comparison

Biological Activity

Target
  • CDK1

    CDK1, Ki:20 nM

In Vitro:

Cell Line
Concentration Treated Time Description Reference
HeLa cells 5 μM 15 min RO-3306 treatment induced dephosphorylation of Gwl at S90 and S453 sites and caused a downshift in Gwl migration band, indicating that RO-3306 promoted Gwl dephosphorylation by inhibiting Cdk1 activity. PMC4749544
HeLa cells 9 μM 20 h Used to synchronize cell divisions and fix cells at metaphase for subsequent experiments. PMC10013866
RPE1 cells 7.5 μM 18 h Synchronize RPE1 cells into G2 phase and arrest them in G2 phase by RO3306 treatment for subsequent cell cycle time course experiments. PMC8143631
HeLa cells 10 μM 12 h To study the effect of RO-3306 on HeLa cells synchronized at the G2/M border, results showed that RO-3306 inhibited Cdk1 activity and delayed mitotic entry. PMC5990311
Glioma stem cells (GSCs) 20 μM 12 h Inhibits CDK1 activity, reduces serine phosphorylation of Ubc9, thereby attenuating the interaction between Pin1 and Ubc9. PMC10762127
muscle satellite cells 0.5 μM 24 h Inhibit Cdk1/Ccnb1 activity, reduce BrdU incorporation in FoxM1-overexpressing muscle satellite cells PMC7062904
HT1376 and HT1197 BC cells 20 μM 2 h RO-3306 increased the expression of ID2, indicating that CDK1 inhibition can enhance ID2 expression. PMC9256744
MDA-MB-231 cells 10 μM 未明確 To examine the effect of proteasome inhibitor MG132 on TWIST1 protein levels, results showed that MG132 could rescue the decreased TWIST1 protein level caused by USP29 knockdown. PMC10104637
MDA-MB-231 cells 10 μM 10 h To examine the effect of USP29 knockdown on TWIST1 ubiquitination levels, results showed that USP29 knockdown significantly increased the ubiquitination level of TWIST1. PMC10104637

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
Mice Orthotopic GBM xenografts Intraperitoneal injection 20 mg/kg Every other day until the end of the experiments Inhibits CDK1 activity, reduces SUMO1-modified protein sumoylation, suppresses tumor growth, and extends mouse survival. PMC10762127
mice FoxM1-overexpressing mice intraperitoneal injection 4 mg/kg 4 times per week for 5 weeks Inhibit Cdk1/Ccnb1 activity, restore the muscle satellite cell pool in FoxM1-overexpressing mice PMC7062904
NSG immunodeficient mice orthotopic BC xenograft model intraperitoneal injection 4 mg/kg every 4 days, 6 times RO-3306 monotherapy inhibited 33.2% of tumor growth, and combination with apigenin inhibited 63.1% of tumor growth, indicating that RO-3306 enhanced the antitumor effect of apigenin. PMC9256744
nude mice breast cancer xenograft model intraperitoneal injection 4 mg/kg every 2 days until sacrifice To examine the effect of CDK1 inhibitor RO-3306 on tumor growth, results showed that RO-3306 significantly inhibited tumor growth. PMC10104637

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.85mL

0.57mL

0.28mL

14.23mL

2.85mL

1.42mL

28.45mL

5.69mL

2.85mL

References

 

Historical Records

Categories